CoChat

Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007

Heinks, Kerstin, Boekhoff, Svenja, Hoffmann, Anika, Warmuth-Metz, Monika, Eveslage, Maria, Peng, Junxiang, Calaminus, Gabriele, Müller, Hermann L. · 2018 · Endocrine
Cited by 77

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12020-017-1489-9

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 30

  1. H.L. Muller, Craniopharyngioma. Endocr. Rev. 35, 513–543 (2014) · DOI · Paper page
  2. H.L. Muller, T.E. Merchant, S. Puget, J.P. Martinez-Barbera, New outlook on the diagnosis, treatment and follow–up of childhood-onset craniopharyngioma. Nat. Rev. Endocrinol. 13, 299–312 (2017) · DOI · Paper page
  3. C.J. de Vile, D.B. Grant, R.D. Hayward, B.E. Kendall, B.G. Neville, R. Stanhope, Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging. J. Clin. Endocrinol. Metab. 81, 2734–2737 (1996)
  4. A. Bereket, W. Kiess, R.H. Lustig et al., Hypothalamic obesity in children. Obes. Rev. 13, 780–798 (2012) · DOI · Paper page
  5. B. Ergun-Longmire, A.C. Mertens, P. Mitby et al., Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J. Clin. Endocrinol. Metab. 91, 3494–3498 (2006) · DOI · Paper page
  6. J.E. Chaplin, B. Kristrom, B. Jonsson et al., Improvements in behaviour and self-esteem following growth hormone treatment in short prepubertal children. Horm. Res Paediatr. 75, 291–303 (2011) · DOI · Paper page
  7. H.L. Muller, Consequences of craniopharyngioma surgery in children. J. Clin. Endocrinol. Metab. 96, 1981–1991 (2011) · DOI · Paper page
  8. H.L. Muller, U. Gebhardt, C. Teske et al., Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. Eur. J. Endocrinol. 165, 17–24 (2011) · DOI · Paper page
  9. H.L. Muller, U. Gebhardt, N. Etavard-Gorris et al., Prognosis and sequela in patients with childhood craniopharyngioma – results of HIT-ENDO and update on KRANIOPHARYNGEOM 2000. Klin. Padiatr. 216, 343–348 (2004) · DOI · Paper page
  10. A. Prader, R.H. Largo, L. Molinari, C. Issler, Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development. Helv. Paediatr. Acta Suppl. 52, 1–125 (1989)
  11. M.F. Rolland-Cachera, T.J. Cole, M. Sempe, J. Tichet, C. Rossignol, A. Charraud, Body Mass Index variations: centiles from birth to 87 years. Eur. J. Clin. Nutr. 45, 13–21 (1991)
  12. G. Calaminus, S. Weinspach, C. Teske, U. Gobel, Quality of life in children and adolescents with cancer. First results of an evaluation of 49 patients with the PEDQOL questionnaire. Klin. Padiatr. 212, 211–215 (2000) · DOI · Paper page
  13. J.E. Wolff, E. Daumling, A. Dirksen, A. Dabrock, M. Hartmann, H. Jurgens, [Munster Heidelberg Abilities Scale–a measuring instrument for global comparison of illness sequelae]. Klin. Padiatr. 208, 294–298 (1996) · DOI · Paper page
  14. H.L. Muller, U. Gebhardt, A. Faldum et al., Functional capacity and body mass index in patients with sellar masses-cross-sectional study on 403 patients diagnosed during childhood and adolescence. Childs Nerv. Sys 21, 539–545 (2005) · DOI
  15. A.M. Pereira, E.M. Schmid, P.J. Schutte et al., High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma. Clin. Endocrinol. 62, 197–204 (2005) · DOI · Paper page
  16. B. Bulow, R. Attewell, L. Hagmar, P. Malmstrom, C.H. Nordstrom, E.M. Erfurth, Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence. J. Clin. Endocrinol. Metab. 83, 3897–3904 (1998)
  17. J.W. Tomlinson, N. Holden, R.K. Hills et al., Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357, 425–431 (2001) · DOI · Paper page
  18. H.L. Muller, K. Bueb, U. Bartels et al., Obesity after childhood craniopharyngioma–German multicenter study on pre-operative risk factors and quality of life. Klin. Padiatr. 213, 244–249 (2001) · DOI · Paper page
  19. P. Kendall-Taylor, P.J. Jonsson, R. Abs et al., The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma. Eur. J. Endocrinol. 152, 557–567 (2005) · DOI · Paper page
  20. H.K. Gleeson, R. Stoeter, A.L. Ogilvy-Stuart, H.R. Gattamaneni, B.M. Brennan, S.M. Shalet, Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement. J. Clin. Endocrinol. Metab. 88, 3682–3689 (2003) · DOI · Paper page
  21. M. Geffner, M. Lundberg, M. Koltowska-Haggstrom et al., Changes in height, weight, and body mass index in children with craniopharyngioma after 3 years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database). J. Clin. Endocrinol. Metab. 89, 5435–5440 (2004) · DOI · Paper page
  22. D.A. Price, P. Wilton, P. Jonsson et al., Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996. Horm. Res. 49, 91–97 (1998)
  23. K.C. Yuen, M. Koltowska-Haggstrom, D.M. Cook et al., Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction. Eur. J. Endocrinol. 169, 511–519 (2013) · DOI · Paper page
  24. I.C. Huang, E.A. Shenkman, W. Leite, C.A. Knapp, L.A. Thompson, D.A. Revicki, Agreement was not found in adolescents’ quality of life rated by parents and adolescents. J. Clin. Epidemiol. 62, 337–346 (2009) · DOI
  25. A. Poretti, M.A. Grotzer, K. Ribi, E. Schonle, E. Boltshauser, Outcome of craniopharyngioma in children: long-term complications and quality of life. Dev. Med. Child. Neurol. 46, 220–229 (2004) · DOI · Paper page
  26. R.B. Levi, D. Drotar, Health-related quality of life in childhood cancer: discrepancy in parent-child reports. Int. J. Cancer Suppl. 2, 58–64 (1999) · DOI
  27. Y.H. Vance, R.C. Morse, M.E. Jenney, C. Eiser, Issues in measuring quality of life in childhood cancer: measures, proxies, and parental mental health. J. Child. Psychol. Psychiatry 42, 661–667 (2001) · DOI · Paper page
  28. J. Verhelst, P. Kendall-Taylor, E.M. Erfurth et al., Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database). J. Clin. Endocrinol. Metab. 90, 4636–4643 (2005) · DOI · Paper page
  29. J.N. Roemmich, M.G. Huerta, S.M. Sundaresan, A.D. Rogol, Alterations in body composition and fat distribution in growth hormone-deficient prepubertal children during growth hormone therapy. Metabolism 50, 537–547 (2001) · DOI
  30. K.C. Calman, Quality of Life in cancer patients - an hypothesis. J. Med. Ethics 10, 124–127 (1984) · DOI · Paper page

Cited by

See all 77

Metadata

Authors
Heinks, K., Boekhoff, S., Hoffmann, A., Warmuth-Metz, M., Eveslage, M., Peng, J., Calaminus, G., & Müller, H. L.
Venue
Endocrine
Published
2017-12-11
Volume
59
Issue
2
Pages
364-372
ISSN
  • 1355-008X
  • 1559-0100
Cited by
77
References
3
Language
en
Funders
  • Deutsche Kinderkrebsstiftung (DKS 2014.13)
  • Pfizer (WI178359)
  • Lilly Deutschland (MQS440-001-TL4-v3)
  • Ferring Pharmaceuticals (CS-10459)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.